Opthea to Present at Oppenheimer Healthcare Conference
Ticker: OPTEY · Form: 6-K · Filed: Feb 7, 2025 · CIK: 1815620
Sentiment: neutral
Topics: conference-presentation, biotech
TL;DR
Opthea presenting at Oppenheimer Healthcare Conference Feb 2025 - watch for updates.
AI Summary
Opthea Limited announced on February 7, 2025, that it will present at the Oppenheimer Healthcare Conference. The company, based in South Yarra, Victoria, Australia, is a foreign issuer filing a Form 6-K report. This presentation is part of their ongoing communication efforts regarding their business developments.
Why It Matters
Opthea's participation in the Oppenheimer Healthcare Conference provides a platform to update investors and the healthcare industry on its progress, potentially influencing its stock valuation and strategic partnerships.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a conference presentation and does not contain significant financial or operational news that would immediately impact risk.
Key Players & Entities
- Opthea Limited (company) — Registrant
- Oppenheimer Healthcare Conference (company) — Event
- February, 2025 (date) — Reporting period and event timing
- 001-39621 (other) — SEC File Number
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing is to report that Opthea Limited will present at the Oppenheimer Healthcare Conference in February 2025.
When is Opthea Limited scheduled to present?
Opthea Limited is scheduled to present during the month of February, 2025.
Which conference will Opthea Limited be presenting at?
Opthea Limited will be presenting at the Oppenheimer Healthcare Conference.
What is Opthea Limited's SEC file number?
Opthea Limited's SEC file number is 001-39621.
Where is Opthea Limited's principal executive office located?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
Filing Stats: 146 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2025-02-07 06:04:31
Filing Documents
- opt_-_opthea_oppenheimer.htm (6-K) — 26KB
- opt-ex99_1.htm (EX-99.1) — 22KB
- img260626642_0.jpg (GRAPHIC) — 151KB
- img260626642_1.jpg (GRAPHIC) — 151KB
- 0000950170-25-015830.txt ( ) — 465KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 02/07/2025